Not finding it? Sign in to also search OpenAlex live.
-
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits
Selina Khan, Sonia Marquez-Martinez, Tim Erkens, Adriaan de Wilde, Lea M. M. Costes, Petra Vinken, +8 more
2citations -
Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity2024 Scientific Reports article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 2 patents
Lucy Rutten, Maarten Swart, Annemart Koornneef, Pascale Bouchier, Sven Blokland, Ava Sadi, +16 more
16citations -
Decoding Neuropathic Pain: Can We Predict Fluctuations of Propagation Speed in Stimulated Peripheral Nerve?2022 Frontiers in Computational Neuroscience article Neuroscience Neuroscience and Neural Engineering Open access
Ekaterina Kutafina, Alina Troglio, Roberto De Col, Rainer Röhrig, Peter Rossmanith, Barbara Namer
15citations -
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine2021 New England Journal of Medicine article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 14 patents
JERALD C. SADOFF, Mathieu Le Gars, Georgi Shukarev, Dirk Heerwegh, Carla Truyers, Anne Marit de Groot, +20 more
1,216citations -
Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses2024 PLoS ONE article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access
Sonia Marquez-Martinez, Nadine C. Salisch, Jan Serroyen, Roland C. Zahn, Selina Khan
5citations